Panel Discussion on Large B-Cell Lymphoma

This VJHemOnc video was recorded at a panel discussion at the 2016 International Workshop on Non-Hodgkin Lymphoma, which was held in San Diego, CA last month. The panel was comprised of Dr. Andrew Zelenetz from the Memorial Sloan-Kettering Cancer Center in New York, Dr. Michael Pfreundschuh from Saarland University in Saarbrücken, Germany, Dr. David Scott from the British Columbia Cancer Agency in Vancouver and Dr. Laura Pasqualucci from the Columbia University Medical Center in New York.

Find out more about why we need clinical trials for lymphoma.

The group discusses the complexity of large B-cell lymphoma and its subtypes, targeted therapies, patient selection for clinical trials and epigenetic modifiers, and look at the data from recent clinical trials for elderly and young high-risk lymphoma patients.

First B-cell lymphoma patients dosed in Phase 1 clinical study of potential new treatment. Find out more.

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

Your email address will not be published. Required fields are marked *